Live-attenuated H7N9 influenza vaccine is weak, yet strong

Lancet Infect Dis. 2016 Mar;16(3):266-7. doi: 10.1016/S1473-3099(15)00425-9. Epub 2015 Dec 8.

Authors

Mark Zanin¹, Richard Webby²

Affiliations

¹ Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA.
² Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: Richard.webby@stjude.org.

PMID: 26673390
DOI: 10.1016/S1473-3099(15)00425-9

No abstract available

Publication types

Comment

MeSH terms

Female
Humans
Influenza A Virus, H7N9 Subtype / immunology*
Influenza Vaccines*
Influenza, Human / prevention & control*
Male

Substances

Influenza Vaccines